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The Role of Oral Antibiotic Preparation in Elective
Colorectal Surgery
A Meta-analysis
Katie E. Rollins, MRCS, Hannah Javanmard-Emamghissi, MRCS,
Austin G. Acheson, DM, FRCS, and Dileep N. Lobo, DM, FRCS, FACS, FRCPEy
Objectives: To compare the impact of the use of oral antibiotics (OAB) with
or without mechanical bowel preparation (MBP) on outcome in elective
colorectal surgery.
Summary Background Data: Meta-analyses have demonstrated that MBP
does not impact upon postoperative morbidity or mortality, and as such it
should not be prescribed routinely. However, recent evidence from large
retrospective cohort and database studies has suggested that there may be a
role for combined OAB and MBP, or OAB alone in the prevention of surgical
site infection (SSI).
Methods: Ameta-analysis of randomized controlled trials and cohort studies
including adult patients undergoing elective colorectal surgery, receiving
OAB with or without MBP was performed. The outcome measures examined
were SSI, anastomotic leak, 30-day mortality, overall morbidity, development
of ileus, reoperation and Clostridium difficile infection.
Results: A total of 40 studies with 69,517 patients (28 randomized controlled
trials, n ¼ 6437 and 12 cohort studies, n ¼ 63,080) were included. The
combination of MBPþOAB versus MBP alone was associated with a
significant reduction in SSI [risk ratio (RR) 0.51, 95% confidence interval
(CI) 0.46–0.56, P< 0.00001, I2¼ 13%], anastomotic leak (RR 0.62, 95% CI
0.55–0.70, P< 0.00001, I2¼ 0%), 30-day mortality (RR 0.58, 95% CI 0.44–
0.76, P< 0.0001, I2¼ 0%), overall morbidity (RR 0.67, 95%CI 0.63–0.71, P
< 0.00001, I2¼ 0%), and development of ileus (RR 0.72, 95% CI 0.52–0.98,
P¼ 0.04, I2¼ 36%), with no difference inClostridium difficile infection rates.
When a combination of MBPþOAB was compared with OAB alone, no
significant difference was seen in SSI or anastomotic leak rates, but there was
a significant reduction in 30-day mortality, and incidence of postoperative
ileus with the combination. There is minimal literature available on the
comparison between combined MBPþOAB versus no preparation, OAB
alone versus no preparation, and OAB versus MBP.
Conclusions: Current evidence suggests a potentially significant role for
OAB preparation, either in combination with MBP or alone, in the prevention
of postoperative complications in elective colorectal surgery. Further high-
quality evidence is required to differentiate between the benefits of combined
MBPþOAB or OAB alone.
Keywords: anastomotic leak, colorectal, mechanical bowel preparation, oral
antibiotics, surgery, surgical site infection
(Ann Surg 2018;xx:xxx–xxx)
S urgical site infection (SSI) is a major burden for patients under-going elective colorectal surgery. It adds significantly to the cost
of health care, and administration of preoperative bowel preparation
has been proposed to reduce the incidence of SSI. The role of
mechanical bowel preparation (MBP) with polyethylene glycol or
sodium phosphate has been studied in randomized controlled trials
(RCTs), with perceived benefits including ease of manipulation of
the bowel, reduced spillage and resultant contamination, reduced
luminal pressure, and lesser bacterial load. However, a recent meta-
analysis1 of 36 RCTs and cohort studies, and an earlier one2 of 14
RCTs found that that the administration of MBP did not impact upon
postoperative morbidity or mortality. This, in combination with high
rates of patient dissatisfaction and fluid and electrolyte disturbances,
has led to the conclusion that MBP should not be prescribed
routinely. This is reflected in Guidelines from the Enhanced Recov-
ery After Surgery Society,3,4 the National Institute of Health and
Care Excellence,5 and the American Society for Enhanced Recov-
ery,6 all of which suggest that MBP should not be administered
routinely. However, although the American Society for Enhanced
Recovery guidelines suggest that MBP should not be given in
isolation, they recommend routine use of an isosmotic bowel prepa-
ration and combined oral antibiotic prior to elective colorectal
surgery.6
The use of oral antibiotic (OAB) prophylaxis, in the form of
nonabsorbable luminal antibiotics, was first proposed in 1971 by
Rosenberg et al7 in a RCT of 150 patients undergoing large bowel
surgery receiving MBP alone, or MBP in combination with phthalyl-
sulphathiazole or phthalylsulphathiazole and neomycin. The combi-
nation of MBPþOAB was associated with a significant reduction in
SSI (23% vs. 40%), anastomotic leak rates (24% vs. 52%), and sepsis
rates (37.3% vs. 64.4%).6 Although several studies provided evidence
for the role of oral antibiotics in elective colorectal surgery, the
regimens included large volume preparations,8–10 prolonged preoper-
ative hospital admission, and in the setting of prolonged preoperative
starvation protocols, dehydration, and electrolyte disturbances were
commonplace.11,12 Decreased compliance and inconsistent bowel
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cleansing resulted in a reduced intervention effect and, this, combined
with reduced preoperative admission times, resulted in the practice of
combined MBPþOAB dwindling in favor of more restrictive MBP
regimens alone. However, recently there has been resurgent interest in
the use ofOAB in colorectal surgery,13,14 particularly in light of a large
number of retrospective cohort and database studies, many of which
originated from the American College of Surgeons National Surgical
Quality Improvement Program (ACS NSQIP) targeted colectomy
database.15–20 Evidence for the role of OAB has been summarized
in several narrative reviews21,22 as well as meta-analyses,23–25 which
have supported a reduction in SSI associated with combined MBP,
OAB, and parenteral antibiotics over MBP and parenteral antibiotics
alone. However, the most recent of these studies have been flawed in
their inclusion of multiple studies based on the NSQIP databasewhich
have large degrees of cross-over of the same study population and have
mostly focused upon SSI alone rather than other postoperative out-
comes. In addition, recent studies18,26 have suggested that OAB alone
may provide equivalent prophylaxis in terms of SSI and anastomotic
leak rates when compared with a combined regimen of MBPþOAB.
The aims of this meta-analysis of RCTs and observational
cohort studies in patients undergoing elective colorectal surgery
were to:
 Compare the impact of OAB with or without MBP in elective
colorectal surgery in terms of SSI, anastomotic leak, 30-day
mortality, overall morbidity, development of ileus, reoperations,
and Clostridium difficile infection.
 Compare evidence derived from RCTs and cohort studies.
 Compare the role of administration of OAB with and without
MBP in the setting of laparoscopic versus open surgery.
METHODS
Search Strategy
The PubMed, Google Scholar, MEDLINE, and the Cochrane
Library databases were searched to identify studies evaluating the
effect of OAB in adults undergoing elective colorectal surgery
published between January 1, 1981 and May 30, 2018. This date
restriction was imposed as recommendations that parenteral anti-
biotics should be administered routinely for prophylaxis against SSI
in colorectal surgery were made in 198127 and it was felt that all
studies considering the role of oral antibiotic prophylaxis should
include parenteral antibiotic prophylaxis, to reflect current perioper-
ative care. The search terms used were: (oral antibiotic OR oral
antibacterial) AND (colon OR rectal OR colorectal) AND surgery.
The bibliographies of all studies which met the inclusion criteria,
and previous systematic reviews and meta-analyses on the subject
were reviewed to ensure study inclusion was as complete as possible.
Non-English-language papers were translated for inclusion. The
meta-analysis was conducted in accordance with the PRISMA
statement.28
Selection of Articles
Articles were screened for suitability on the basis of title and
abstract by 2 independent researchers (K.E.R. and H.J.-E.). Studies
were eligible for inclusion if they examined the role of OAB
preparation with or without MBP, compared with either MBP alone,
OAB alone, or no preparation in adult patients due to undergo
elective colorectal surgery, with at least 1 relevant clinical outcome
reported. The type of colorectal surgery performed in terms of type of
resection or laparoscopic versus open, the presence or absence of
rectal enema administration, or the indication for surgery were not
discriminants. Studies were excluded if they did not consider any
relevant clinical outcomes, included emergency procedures, or
duplicated study populations from other included studies. From
the large number of ACS NSQIP studies published15–20,26,29–40
(Supplementary Table 1, http://links.lww.com/SLA/B542), only
the largest study by Midura et al31 was included to avoid the risk
of duplication of patient populations within the analysis. Similarly, 3
publications41–43 originated from the Michigan Surgical Quality
Collaborative Colectomy Best Practices Project. When these were
reviewed, 2 studies41,42 considered the same comparison of prepa-
rations (MBPþOAB vs no preparation), and as such only the more
comprehensive study including a larger number of clinical outcomes
was included.41 The third study from the Michigan Surgical Quality
Collaborative database43 examined a different preparation combina-
tion, thus this was included in the meta-analysis. Finally, the national
Veterans Affairs Surgical Quality Improvement Program was the
basis for 2 studies44,45 on the same regimen comparison, thus only the
largest study was included within the meta-analysis.45 One study46
included a small proportion of patients undergoing emergency
colorectal resection within the cohort (311 of a total population of
2240), so any outcomes that included this study were analyzed both
with and without it included to discern any difference in results.
Data Extraction
Data were extracted by 2 independent researchers (K.E.R. and
H.J.-E.) and any discrepancies were resolved by a senior author
(D.N.L.). The primary outcome measure was SSI, with secondary
outcome measures including anastomotic leak, 30-day mortality,
overall morbidity, development of ileus, reoperation, and Clostrid-
ium difficile infection. Data were also collected on patient demo-
graphics (age, sex), surgical variables (type of resection, open vs.
laparoscopic, underlying disease necessitating resection), and details
of the preparation used, in terms of parenteral and oral antibiotics as
well asMBP. Several studies stated thatMBPwas not used in patients
with obstructing masses, which is mirrored in standard clinical
practice, thus these papers were included in the meta-analysis.
The risk of bias was assessed for the RCTs included using the
Cochrane Collaboration tool within the RevMan software47 which
considers random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and personnel
(performance bias), blinding of outcome assessment (detection bias),
incomplete outcome data (attrition bias), and selective reporting
(reporting bias).
Statistical Analysis
Data were entered into RevMan 5.3 software.47 Dichotomous
variables were calculated as risk ratios (RR) with a 95% confidence
interval using the Mantel–Haenszel random effects model. From this,
forest plots were derived, with a P value of less than 0.05 on 2-tailed
testing representing a statistically significant difference. Data from
RCTs and cohort studies were included separately within each forest
plot, with a summative analysis of all the evidence performed in
addition. Inconsistency and heterogeneity between studies were esti-
mated using the I2 statistic;48 25% represented low heterogeneity,
25% to 50% represented moderate, and >50% high heterogeneity.
Protocol Registration
The protocol for this meta-analysis was registered with the
PROSPERO database (www.crd.york.ac.uk/prospero)—registration
number CRD42018098950.
RESULTS
From the 520 studies identified in the initial search, 40
studies31,41,43,45,46,49–83 on 69,517 participants were included
(Supplementary Figure 1, http://links.lww.com/SLA/B542). Of these
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28 were RCTs with 6437 participants49–53,55–59,61–67,69–73,75,76,78–
80,83 and 12 were cohort (case control) studies with 63,080 partic-
ipants.31,41,43,45,46,54,60,68,74,77,81,82 The risk of bias in the RCTs
included was variable, with poor levels of documentation particularly
surrounding randomization methods, allocation concealment, and
blinding in the earlier studies (Table 1). Six studies57,58,62,64–66
administered different parenteral antibiotic regimens depending
upon whether the patient was receiving MBPþOAB or MBP alone,
which may provide significant source of bias in terms of SSI
prevention. In addition, 1 study73 included 2 differing parenteral
antibiotic regimens, both in combination with MBP, versus OAB,
MBP and parenteral antibiotics. As both of the parenteral antibiotic
regimens were considered eligible for inclusion, these were grouped
together to form the MBP alone group. In terms of oral antibiotics, 2
studies administered OAB preparation only on the day of surgery;
one64 gave ciprofloxacin 1 g 1 hour preoperatively and the other74
ciprofloxacin 750mg 1 to 3 hour preoperatively. A subgroup of
another study51 received only 1 dose of OAB the day before surgery,
with the remainder receiving 3 doses. These 3 studies may, therefore,
have an attenuated the intervention effect from the OAB adminis-
tered.
Patient Demographics
Two studies53,55 focused on surgery using laparoscopic tech-
niques, 21 on open surgery alone,46,50,52,57,58,61,62,64–74,76,78,80 with 9
studies41,43,49,54,60,75,77,81,82 mixing both open and laparoscopic tech-
niques and the remaining 8 studies not providing this informa-
tion.31,45,51,56,59,63,79,83 The most recent publication31 included
patients undergoing robotic surgery. The indication for surgery
was colorectal cancer in 8 studies,46,54,55,59,61,75,78,81 inflammatory
bowel disease in 2,67,80 with the remaining including a mixture of
benign and malignant pathologies. Patient demographics and
TABLE 1. Risk of Bias Within Randomized Controlled Trials Included Within the Meta-analysis
Reference
Random
Sequence
Generation
Allocation
Concealment
Blinding of
Participants
and Personnel
Blinding of
Outcome
Assessment
Incomplete
Outcome
Data
Selective
Reporting Other Bias
Anjum et al 201749 þ þ ? þ þ þ
Coppa et al 199850 ? ?  þ  
Espin-Basany et al 200551 ? ? ? þ þ þ
Hanel et al 198052  ? ? þ  þ
Hata et al 201653 þ þ   þ þ 36 patients in the MBPþOAB
group received reduced
doses of kanamycin due to
prescription error
Ikeda et al 201655 þ þ  þ þ þ
Ishida et al 200156 þ    þ ?
Kaiser et al 198357 ? þ þ þ þ  Different IV antibiotic regimens
given to the 2 groups
Khubchandani et al 198958 ? ? þ þ   Different IV antibiotic regimens
given to the 2 groups
Kobayashi et al 200759 þ ?    
Lau et al 198861 þ ? ? ? þ þ
Lazorthes et al 198262 ? ? ? ? ?  Different IV antibiotic regimens
given to the 2 groups
Lewis 200263   þ þ þ þ
McArdle et al 199564 ? ? ? ? þ ? Different IV antibiotic regimens
given to the 2 groups
Monrozies et al 198365 ? ? ? ? þ þ Different IV antibiotic regimens
given to the 2 groups
Nohr et al 199066 ? ? þ þ  þ Different IV antibiotic regimens
given to the 2 groups
Oshima et al 201367 ? ?   þ þ
Peruzzo et al 198769 ? ? ? ? þ þ
Playforth et al 198870 ? ? ? ? þ þ
Ram et al 200571  ? ? ? þ þ
Reddy et al 200772 þ þ   þ þ Group also randomized to
probiotics—not included
within meta-analysis
Reynolds et al 198973 þ  ? ?   Two different IV antibiotic
regimens in the MBP group
Sadahiro et al 201475 þ  þ þ ? ? Group also randomized to
probiotics—not included
within meta-analysis
Stellato et al 199076 þ ? þ þ  þ
Takesue et al 200078 ? ? ? ?  ?
Taylor et al 199479 ? ?    þ
Uchino et al 201780 þ þ  þ  ? C difficile toxin and faecal
cultures only preop
Zmora et al 200383 þ þ ? ?  þ
þ indicates low risk of bias; , high risk of bias; ?, unclear risk of bias.
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surgical variables as well as the details of MBP, OAB, and parenteral
antibiotics administered are detailed in Table 2.
Surgical Site Infection (SSI)
MBPROAB Versus MBP
The comparison between MBPþOAB versus MBP alone was
performed in 35 studies; 26 RCTs49–53,55–59,61–67,69,70,72,73,75,76,78–80
and 9 cohort studies31,43,45,54,60,68,74,77,81 with a total of 47,610
patients. When all studies were considered (Fig. 1), the combination
of MBPþOAB was associated with a significant reduction in SSI
versus MBP alone (RR 0.51, 95% CI 0.46–0.56, P < 0.00001, I2 ¼
13%). The results remained consistent when just RCT studies were
examined (5378 patients; RR0.57, 95%CI 0.48–0.68,P< 0.00001, I2
¼ 12%), as well as cohort studies (42,232 patients; RR 0.48, 95% CI
0.44–0.51, P < 0.00001, I2 ¼ 0%).
FIGURE 1. Forest plot comparing surgical site infection rate for patients receivingMBPþOAB versusMBP alone, divided by evidence
from RCTs and cohort studies. A Mantel–Haenszel random effects model was used to perform the meta-analysis and risk ratios are
quoted including 95% confidence intervals.
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MBPROAB Versus OAB
The analysis of MBPþOAB versus OAB alone was consid-
ered by 4 studies; 2 RCTs71,83 and 2 cohort studies31,45 including
23,483 patients (Fig. 2). Overall, the combination of MBPþOAB
was not associated with any difference in the incidence of SSI versus
OAB alone (RR 0.98, 95% CI 0.64–1.50, P ¼ 0.92), with high
heterogeneity (I2¼ 77%). When RCTs alone were considered, again
no difference was seen (RR 1.36, 95% CI 0.78–2.35, P ¼ 0.28, I2 ¼
0%), as with cohort studies (RR 0.83, 95%CI 0.48–1.43, P¼ 0.51, I2
¼ 90%).
MBPROAB Versus No Preparation
No RCTs considered the comparison between combined
MBPþOAB and no preparation, with evidence arising from just 4
cohort studies (36,642 patients).31,41,45,46 The combination of
MBPþOAB was associated with a significant reduction in SSI
(RR 0.54, 95% CI 0.43–0.68, P < 0.00001, I2 ¼ 82%) when
compared with no preparation.
OAB Alone Versus No Preparation
NoRCTs focusedupon thecomparisonbetweenOABaloneversus
no preparation, with evidence arising from 16,390 patients included in 2
cohort studies.31,45 OAB alone reduced the incidence of SSI versus no
preparation (RR 0.56, 95% CI 0.38–0.83, P ¼ 0.004, I2 ¼ 81%).
OAB Versus MBP
Two studies31,45 considered the incidence of SSI with OAB
alone versus MBP alone, with OAB associated with a reduction in
SSI rates. However, this did not reach statistical significance (RR
0.57, 95% CI 0.31–1.05, P ¼ 0.07, I2 ¼ 93%).
Anastomotic Leak
MBPROAB Versus MBP
Rates of anastomotic leak in those receiving combined
MBPþOAB versus MBP alone were compared in 22 studies
(Fig. 3); 17 RCTs49–53,55,56,58,61,63,64,66,69,70,75,76,78 and 5 cohort
studies.31,68,74,77,81 Only 2 RCTs49,52 included data regarding the
management of the anastomotic leak, with none of the 124 patients
receiving combined MBPþOAB requiring return to theater for
anastomotic leakage compared with 2 of 127 patients receiving
MBP alone. Overall, the combination of MBPþOAB was associated
with a significant reduction in anastomotic leak rates (RR 0.62, 95%
CI 0.55–0.70, P < 0.00001, I2 ¼ 0%), and when evidence from
cohort studies alone was considered (RR 0.45, 95% CI 0.25–0.80, P
¼ 0.007, I2 ¼ 22%), but no significant difference was seen when
RCTs were analyzed (RR 0.69, 95% CI 0.43–1.11, P ¼ 0.13, I2 ¼
0%). Six studies51,53,55,68,77,81 included data on the use of a diverting
stoma, with 133 patients of 1028 in the combined MBPþOAB group
and 99 patients of 862 in the MBP alone group undergoing a
protective stoma formation.
MBPROAB Versus OAB
The combination of MBPþOAB versus OAB alone was
considered by 3 studies; 2 RCTs71,83 and 1 cohort study,31 with
no difference observed in anastomotic leak rates when all studies (RR
0.79, 95% CI 0.59–1.05, P¼ 0.11, I2¼ 0%), or just RCTs (RR 1.39,
95% CI 0.47–4.10, P ¼ 0.55, I2 ¼ 0%) were considered (Supple-
mentary Figure 2, http://links.lww.com/SLA/B542). No data were
available on return to theater rates related to anastomotic leaks.
MBPROAB Versus No Preparation
The comparison between MBPþOAB versus no preparation
in terms of anastomotic leak was considered by just 2 cohort
studies,31,46 with combined MBPþOAB being associated with a
significant reduction in anastomotic leak rates (RR 0.52, 95% CI
0.45–0.59, P < 0.00001, I2 ¼ 0%). No data were available on return
to theater rates secondary to anastomotic leaks or diverting
stoma rates.
Other Comparisons
The comparison of anastomotic leak rates between OAB alone
versus no preparation and OAB versus MBP was each only consid-
ered by 1 cohort study,31 and as such meta-analysis was not feasible.
FIGURE 2. Forest plot comparing surgical site infection rate for patients receivingMBPþOAB versus OAB alone, divided by evidence
from RCTs and cohort studies. A Mantel–Haenszel random effects model was used to perform the meta-analysis and risk ratios are
quoted including 95% confidence intervals.
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30-day Mortality
MBPROAB Versus MBP
Seventeen studies (35,633 patients) examined 30-day mortal-
ity rates between those receiving MBPþOAB versus MBP alone; 14
RCTs49,50,52,55,58,59,62,64–66,70,72,76,79 and 3 cohort studies31,68,74
(Fig. 4). Overall, the combination of MBPþOAB was associated
with a significant reduction in 30-day mortality versus MBP alone
(RR 0.58, 95% CI 0.44–0.76, P < 0.0001, I2 ¼ 0%). This was also
the case when evidence arising from cohort studies alone was
considered (RR 0.56, 95% CI 0.42–0.76, P ¼ 0.0002, I2 ¼ 0%),
but not when RCTs alone were examined (RR 0.66, 95% CI 0.35–
1.25, P ¼ 0.20, I2 ¼ 0%).
MBPROAB Versus OAB
Three studies (2 RCTs71,83 and 1 cohort study31) including
19,360 patients considered 30-day mortality in those receiving
MBPþOAB versus OAB alone (Supplementary Figure 3, http://link-
s.lww.com/SLA/B542), with the combination being associated with a
significant reduction in 30-day mortality in all studies (RR 0.58, 95%
CI 0.34–0.97, P ¼ 0.04, I2 ¼ 0%). However, no difference was
observed in RCTs (RR 1.02, 95% CI 0.30–3.50, P ¼ 0.97, I2 ¼ 0%).
MBPROAB Versus No Preparation
Just 2 cohort studies31,46 including 29,350 patients considered
the impact of MBPþOAB versus no preparation on 30-day mortality.
The combination of MBPþOAB was associated with a significant
reduction in 30-day mortality (RR 0.36, 95% CI 0.17–0.76, P ¼
0.008, I2 ¼ 46%).
Other Comparisons
Comparison of 30-day mortality between those receiving
OAB versus no preparation and OAB versus MBP included just a
single cohort study,31 thus meta-analysis was not conducted.
Overall Morbidity
Only studies comparing MBPþOAB versus MBP alone were
considered in terms of overall morbidity rates due to a paucity of data
available for all other comparisons. When all 6 studies31,61,62,66,68,76
FIGURE 3. Forest plot comparing anastomotic leak rate for patients receiving MBPþOAB versus MBP alone, divided by evidence
from RCTs and cohort studies. A Mantel–Haenszel random effects model was used to perform the meta-analysis and risk ratios are
quoted including 95% confidence intervals.
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(32,568 patients) were compared, the combination ofMBPþOABwas
associated a significant reduction in overall morbidity (RR 0.67, 95%
CI 0.63–0.71, P< 0.00001, I2¼ 0%), as well as when evidence from
cohort studies alone31,68 was considered (RR 0.67, 95%CI 0.63–0.71,
P< 0.00001, I2¼ 0%). However, with RCTs alone,61,62,66,76 therewas
no difference in overall morbidity between preparation methods (RR
0.71, 95% CI 0.41–1.24, P ¼ 0.23, I2 ¼ 9%).
Development of Ileus
MBPROAB Versus MBP
Five studies31,43,51,53,54 were included in the comparison of
MBPþOAB versus MBP; 2 RCTs51,53 (879 patients) and 3 cohort
studies (33,119 patients).31,43,54 Only 1 study43 provided a definition
of ileus, with the other 4 studies31,43,53,54 not providing a definition.
Overall, the combination of MBPþOAB was associated a significant
reduction in the incidence of postoperative ileus (RR 0.72, 95% CI
0.52–0.98, P ¼ 0.04, I2 ¼ 36%). However, no difference was seen
when just RCTs were considered (RR 0.62, 95% CI 0.14–2.67, P ¼
0.52, I2¼ 50%) or cohort studies alone (RR 0.68, 95% CI 0.45–1.03,
P ¼ 0.07, I2 ¼ 53%).
MBPROAB Versus OAB
Three studies31,71,83 were included in the comparison between
MBPþOAB versus OAB; 2 RCTs71,83 and 1 cohort study.31 None of
these studies provided a definition for ileus. Overall, the combination
of MBPþOAB was associated with a significant reduction in the
incidence of postoperative ileus (RR 0.83, 95% CI 0.73–0.95, P ¼
0.008, I2 ¼ 0%), mostly determined by the large single cohort
study.31 However, no difference was seen when RCTs were consid-
ered (RR 1.25, 95% CI 0.68–2.33, P ¼ 0.47, I2 ¼ 0%).
MBPROAB Versus No Preparation
No RCTs considered the comparison between MBPþOAB
versus no preparation, with evidence arising from 2 cohort studies
only.31,41 Only 1 study41 provided a definition of ileus. This demon-
strated that the combination of MBPþOAB was associated with a
significant reduction in ileus (RR 0.72, 95% CI 0.68–0.77, P <
0.00001, I2 ¼ 0%).
Other Comparisons
The comparison in reoperation rates between OAB
alone versus no preparation and OAB versus MBP were each only
considered by 1 cohort study,31 thus meta-analysis was not per-
formed.
Reoperation
Insufficient data were available for any of the planned anal-
yses on reoperation rates, with 2 studies including data comparing
MBPþOAB versus MBP (1 RCT49 and 1 cohort study31), and just 2
FIGURE 4. Forest plot comparing 30-day mortality rates for patients receiving MBPþOAB versus MBP alone, divided by evidence
from RCTs and cohort studies. A Mantel–Haenszel random effects model was used to perform the meta-analysis and risk ratios are
quoted including 95% confidence intervals.
Rollins et al Annals of Surgery  Volume XX, Number XX, Month 2018
12 | www.annalsofsurgery.com  2018 The Author(s). Published by Wolters Kluwer Health, Inc.
CE: D.C.; ANNSURG-D-18-01552; Total nos of Pages: 16;
ANNSURG-D-18-01552
studies comparing MBPþOAB versus OAB alone (again 1 RCT71
and 1 cohort study).31 Thus, no meta-analysis was performed. The
comparisons of reoperation rates between MBPþOAB versus no
preparation, OAB alone versus no preparation and OAB versus MBP
were each only considered by 1 cohort study,31 and as such meta-
analysis was not performed. However, the largest cohort study31
showed a significant reduction (P < 0.001) in reoperation rates with
combined MBPþOAB (3.2%) compared with OAB alone (4.7%),
MBP alone (4.2%), and no preparation (4.5%).
Clostridium difficile Infection
MBPROAB Versus MBP
Data on Clostridium difficile infection were sufficient only for
the comparison between MBPþOAB versus MBP alone, with data
from 14 studies, including 10 RCTs53,55,61,62,65,67,69,75,78,80 and 4
cohort studies.43,54,68,82 No difference in C difficile infection rates
were seen when all evidencewas considered (RR 0.94, 95%CI 0.55–
1.61, P ¼ 0.81, I2 ¼ 37%), nor when just RCT studies or cohort
studies alone were analyzed (RR 0.79, 95% CI 0.21–2.96, P ¼ 0.72,
I2 ¼ 10% and RR 0.97, 95% CI 0.54–1.75, P ¼ 0.92, I2 ¼ 64%,
respectively).
Laparoscopic Versus Open Procedures
Nineteen RCTs50,52,57,58,61–67,69,70,72–74,76,79,80 provided data
on SSI rates in patients undergoing open elective colorectal proce-
dures between patients receiving combinedMBPþOAB versus MBP
alone, and 2 RCTs53,55 provided data on laparoscopic procedures
alone. The remaining studies included either both open and laparo-
scopic procedures which could not be separated for analysis or did
not state the surgical approach. No other comparison between
preparations was considered due to a paucity of data. The combina-
tion of MBPþOAB versus MBP alone was associated with a
significant reduction in SSI rates in patients undergoing an open
resection (RR 0.55, 95% CI 0.44–0.69, P < 0.00001, I2 ¼ 5%);
however, no significant difference was seen in patients undergoing a
laparoscopic procedure (RR 0.74, 95% CI 0.43–1.29, P¼ 0.29, I2 ¼
50%), although it should be borne in mind that this evidence was
based upon 2 studies (1090 patients).
When anastomotic leak rates were compared between
MBPþOAB versus MBP alone, divided by open and laparoscopic
procedures, data could be analyzed from 9 RCTs50,52,58,61,64,66,69,70,76
in the opengroup and2RCTs53,55 in the laparoscopic group. Therewas
no significant difference in anastomotic leak rates in either the open or
laparoscopic groups (RR 0.69, 95%CI 0.30–1.60,P¼ 0.39, I2¼ 13%
and RR 0.68, 95% CI 0.28–1.65, P ¼ 0.39, I2 ¼ 0%, respectively).
DISCUSSION
Main Findings
This meta-analysis has provided evidence to suggest that
MBPþOAB should be given serious consideration in patients under-
going elective colorectal surgery to reduce the risk of SSI. In
addition, it has shown that the combination of MBPþOAB is
associated with significant reductions in anastomotic leak rates,
30-day mortality, overall morbidity, and the incidence of postopera-
tive ileus, without increasing the risk of developing C difficile
infection (Table 3). Its findings are in contradiction with previous
meta-analyses1,2 that did not account for the role of luminal anti-
biotics and showed that MBP on its own was of no benefit when
compared with no bowel preparation or rectal enemas alone.
However, as only 9.3% (6437 patients) of the 69,517 patients
included were studied in the context of RCTs, the results must be
interpreted with some caution. Hence, when evidence arising from
RCTs alone was considered, the combination of MBPþOAB was
associated with a significant reduction in SSI alone. The evidence for
the combination of MBPþOAB to reduce SSI rates is, thus, strong.
European data reporting the results of colorectal surgery in the
context of Enhanced Recovery After Surgery protocols where
mechanical bowel preparation is not used routinely, have shown
SSI rates of >10%,84,85 whereas the US NSQIP studies have shown
that SSI rates are approximately 3% with a combination of
MBPþOAB, 6% with MBP alone and 7% with no preparation.31
When the combination of MBPþOAB was compared with
OAB alone, a significant reduction in 30-day mortality and incidence
of postoperative ileus was seen, but no difference was seen between
the 2 preparations in RCTs alone. There are no RCTs focusing on the
combinations of MBPþOAB versus no preparation, OAB alone
versus no preparation or OAB alone versus MBP alone. However,
evidence from cohort studies suggests that the combination of
MBPþOAB versus no preparation is associated with a significant
reduction in SSI, anastomotic leak, 30-day mortality, and postopera-
tive ileus. For OAB versus no preparation, the only significant
reduction was in SSI rates, and for OAB versus MBP there was
no significant difference in any of the clinical outcome measures.
When a planned subgroup analysis of patients undergoing open
versus laparoscopic surgery was undertaken, the combination of
MBPþOAB versus MBP alone was associated with a significant
reduction in SSI rates in patients undergoing open procedures, but not
in those undergoing laparoscopic procedures.
Strengths and Weaknesses
The main weakness of this meta-analysis is the inclusion of
both RCTs and cohort studies.While this lowers the overall quality of
evidence, the decision to include cohort studies and large database
studies was made as a large proportion of the recent evidence
supporting the potential role of OAB or combined MBPþOAB
has arisen from such studies. However, every analysis was conducted
separately using evidence from RCTand cohort studies alone, as well
as a summative analysis, to provide a more robust interpretation of
the data.
The role of parenteral antibiotic prophylaxis is considered a
standard of care in current practice, with evidence published in
198127 providing evidence for its benefit in terms of infection
prevention and overall mortality and dictating that no further placebo
or no intervention trials should be conducted. Definitive support was
provided in a Cochrane Review86 demonstrating a significant reduc-
tion in SSI in patients receiving parenteral antibiotic prophylaxis
versus those receiving no antibiotics or placebo (RR 0.34, 95% CI
0.28–0.41, P < 0.0001).
The practice of mechanical bowel preparation has changed
significantly since the early 1980s. The regimen of Lazorthes et al62
included admission 3 days prior to surgery and administration of a
low-residue diet and standard mechanical procedures such as enemas
and magnesium sulphate purges. In contrast, more modern regimens
are typically administered the day before surgery and are less
invasive. This is particularly important in the setting of prolonged
starvation protocols in vogue prior to the more modern ones, as they
resulted in increased preoperative dehydration and electrolyte dis-
turbances which are known to have adverse effects on postoperative
complications. It should, however, be considered that each study
level comparison between preparation types should have been
exposed to the same level of bias, thus making the results more
comparable. The OAB agent, dosing, and timing as well as the
parenteral antibiotic details were also inconsistent between studies,
with insufficient data from each differing combination to perform a
meaningful analysis. Several included just 1 preoperative dose of
OAB, or differing parenteral antibiotic regimens depending upon
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which preparation regimen the patient received which exerts a
potential significant bias. In addition, because of limited data, we
have been unable to discern conclusively whether the reduction in
morbidity is a result of OAB on their own or in combination
with MBP.
The definition of anastomotic leak was not stipulated for
inclusion within this meta-analysis, with the data from each indi-
vidual study included, irrespective of whether this was based upon
clinical or radiological diagnosis of anastomotic leak. However, the
definition of leak was consistent within individual studies, thus the
data from each study were comparable, attenuating this
potential weakness.
Interpretation of the Data in Context of Other
Recent Studies
A recent meta-analysis25 included 23 RCTs and 8 cohort
studies published between 1980 and 2015. However, multiple cohort
studies arising from the NSQIP database were included within this
study,25 and this probably represents multiple reporting of the same
patient datasets. This study25 reported a significant reduction in SSI
rates in patients included within cohort studies receiving MBP, OAB,
and IV antibiotics versus those receiving MBP and IV antibiotics
alone (RR 0.48, 95% CI 0.44–0.52, P ¼ 0.00001, I2 ¼ 45%).
However, 4 of the 5 studies included within this analysis arose from
the ACS NSQIP database. Bellows et al23 previously performed a
meta-analysis on the role of oral nonabsorbable and intravenous
antibiotics versus intravenous antibiotics alone in colorectal surgery,
focusing on SSI. This study included 16 RCTs encompassing 2669
patients published between 1980 and 2011, with all studies including
MBP within the protocol. This meta-analysis found that the combi-
nation of oral and IV antibiotics versus IV antibiotics alone was
associated with a significant reduction in wound infection rates (RR
0.57, 95% CI 0.43–0.76, P ¼ 0.0002, I2 ¼ 19%), but no significant
difference in anastomotic leak rates (RR 0.63, 95% CI 0.28–1.41, P
¼ 0.3, I2¼ 0%). The findings of the currently reported meta-analysis
coincide with the results of these previous meta-analyses.
TABLE 3. Overall Summary of Results
Preparation Considered Outcome Measure All Studies RCTs Only Cohort Studies Only
MBPþOAB vs. MBP Surgical site
infection
Significant # with MBPþOAB
(RR 0.51, 95% CI 0.46–0.56, P <
0.00001, I
2 ¼ 13%)
Significant # with MBPþOAB
(RR 0.57, 95% CI 0.48–0.68, P <
0.00001, I
2 ¼ 12%)
Significant # with MBPþOAB
(RR 0.48, 95% CI 0.44–0.51, P <
0.00001, I
2 ¼ 0%
Anastomotic leak Significant # with MBPþOAB
(RR 0.62, 95% CI 0.55–0.70, P <
0.00001, I
2 ¼ 0%)
No difference
(RR 0.69, 95% CI 0.43–1.11, P ¼
0.13, I
2 ¼ 0%)
Significant # with MBPþOAB
(RR 0.45, 95% CI 0.25–0.80, P ¼
0.007, I
2 ¼ 22%)
30-day mortality Significant # with MBPþOAB
(RR 0.58, 95% CI 0.44–0.76, P <
0.0001, I
2 ¼ 0%)
No difference
(RR 0.66, 95% CI 0.35–1.25, P ¼
0.20, I
2 ¼ 0%)
Significant # with MBPþOAB
(RR 0.56, 95% CI 0.42–0.76, P ¼
0.0002, I
2 ¼ 0%)
Overall morbidity Significant # with MBPþOAB
(RR 0.67, 95% CI 0.63–0.71, P <
0.00001, I
2 ¼ 0%)
No difference
(RR 0.71, 95% CI 0.41–1.24, P ¼
0.23, I
2 ¼ 9%)
Significant # with MBPþOAB
(RR 0.67, 95% CI 0.63–0.71, P <
0.00001, I
2 ¼ 0%)
Development of ileus Significant # with MBPþOAB
(RR 0.72, 95% CI 0.52–0.98, P ¼ 0.04,
I
2 ¼ 36%)
No difference
(RR 0.62, 95% CI 0.14–2.67, P ¼
0.52, I
2 ¼ 50%)
No difference
(RR 0.68, 95% CI 0.45–1.03, P ¼
0.07, I
2 ¼ 53%)
C difficile infection No difference
(RR 0.94, 95% CI 0.55–1.61, P ¼ 0.81,
I
2 ¼ 37%)
No difference
(RR 0.79, 95% CI 0.21–2.96, P ¼
0.72, I
2 ¼ 10%)
No difference
(RR 0.97, 95% CI 0.54–1.75, P ¼
0.92, I
2 ¼ 64%)
MBPþOAB vs. OAB Surgical site infection No difference
(RR 0.98, 95% CI 0.64–1.50, P ¼ 0.92,
I
2 ¼ 77%)
No difference
(RR 1.36, 95% CI 0.78–2.35, P ¼
0.28, I
2 ¼ 0%)
No difference
(RR 0.83, 95% CI 0.48–1.43, P ¼
0.51, I
2 ¼ 90%)
Anastomotic leak No difference
(RR 0.79, 95% CI 0.59–1.05, P ¼ 0.11,
I
2 ¼ 0%)
No difference
(RR 1.39, 95% CI 0.47–4.10, P ¼
0.55, I
2 ¼ 0%)
—
30-day mortality Significant # with MBPþOAB
(RR 0.58, 95% CI 0.34–0.97, P ¼ 0.04,
I
2 ¼ 0%)
No difference
(RR 1.02, 95% CI 0.30–3.50, P ¼
0.97, I
2 ¼ 0%)
—
Overall morbidity — — —
Development of ileus Significant # with MBPþOAB
(RR 0.83, 95% CI 0.73–0.95, P ¼
0.008, I
2 ¼ 0%)
No difference
(RR 1.25, 95% CI 0.68–2.33, P ¼
0.47, I
2 ¼ 0%)
—
C difficile infection — — —
MBPþOAB vs. no
preparation
Surgical site infection — — Significant # with MBPþOAB
(RR 0.54, 95% CI 0.43–0.68, P <
0.00001, I
2 ¼ 82%)
Anastomotic Leak — — Significant # with MBPþOAB
(RR 0.52, 95% CI 0.45–0.59, P <
0.00001, I
2 ¼ 0%)
30-day mortality — — Significant # with MBPþOAB
(RR 0.36, 95% CI 0.17–0.76, P ¼
0.008, I
2 ¼ 46%)
Overall morbidity — — —
Development of ileus — — Significant # with MBPþOAB
(RR 0.72, 95% CI 0.68–0.77, P <
0.00001, I
2 ¼ 0%)
C difficile infection — — —
— indicates insufficient data for conduct of meta-analysis; OAB versus no preparation: only outcome was surgical site infection in cohort studies alone which demonstrated a
significant # with OAB. OAB versus MBP: only outcome was surgical site infection in cohort studies alone which demonstrated no difference.
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CONCLUSION
The present meta-analysis is the largest and most comprehen-
sive to date examining the role of bowel preparation prior to
colorectal surgery, and supports a potentially significant benefit
for OAB preparation, either in combination with MBP or alone,
in the prevention of postoperative complications. While evidence
arising from large retrospective cohort and database studies suggests
a strong positive benefit, these are tempered when evidence arising
from RCTs alone is considered. However, the evidence presented
would suggest a benefit fromOAB preparation in terms of SSI, which
represents a major source of morbidity and increased healthcare
costs. Further high-quality evidence is required to differentiate
between the benefits of combined MBPþOAB or OAB alone in
this setting before more definitive recommendations can be made.
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